ICU MEDICAL INC/DE ICUI
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
2.9
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.2B | $732,000 | $822.0M | $91.8M | $2.1B |
| 2024 | $2.4B | -$117.7M | $824.8M | $124.7M | $2.0B |
| 2023 | $2.3B | -$29.7M | $739.9M | $82.3M | $2.1B |
| 2022 | $2.3B | -$74.3M | $697.8M | -$152.4M | $2.1B |
| 2021 | $1.3B | $103.1M | $491.5M | $199.0M | $1.6B |
| 2020 | $1.3B | $86.9M | $461.5M | $130.7M | $1.5B |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.9 (safe)
- Working capital / assets 0.171
- Retained earnings / assets 0.171
- EBIT / assets 0.011
- Equity / liabilities 1.102
Source: SEC EDGAR filings · CIK 0000883984 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.